Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases

Background. Early diagnosis and treatment are crucial in invasive fungal diseases (IFD). Serum (1-3)-β-d-glucan (BG) is believed to be an early IFD marker, but its diagnostic performance has been ambiguous, with insufficient data regarding sensitivity at the time of IFD diagnosis (TOD) and according...

Descripción completa

Detalles Bibliográficos
Autores principales: Angebault, Cécile, Lanternier, Fanny, Dalle, Frédéric, Schrimpf, Cécile, Roupie, Anne-Laure, Dupuis, Aurélie, Agathine, Aurélie, Scemla, Anne, Paubelle, Etienne, Caillot, Denis, Neven, Bénédicte, Frange, Pierre, Suarez, Felipe, d'Enfert, Christophe, Lortholary, Olivier, Bougnoux, Marie-Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942764/
https://www.ncbi.nlm.nih.gov/pubmed/27419189
http://dx.doi.org/10.1093/ofid/ofw128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942764/
https://www.ncbi.nlm.nih.gov/pubmed/27419189
http://dx.doi.org/10.1093/ofid/ofw128

Ejemplares similares